On This Episode:
The perioperative environment is increasingly shaped by factors that extend beyond traditional pharmacology, requiring anesthesia providers to stay alert to emerging and often underrecognized influences on patient care. One such factor is the growing use of kratom, a plant-derived substance that patients frequently perceive as harmless due to its “natural” origins. However, as highlighted in today’s show, this assumption can lead to critical gaps in disclosure, leaving clinicians unaware of a substance that may significantly alter anesthetic management and patient outcomes.
Given its rising prevalence and potential for serious perioperative implications, kratom use demands a proactive and informed approach. Effective management begins with thorough preoperative assessment and extends to flexible, multimodal anesthetic strategies tailored to the individual patient. Recognizing kratom’s impact is no longer optional—it is essential for ensuring patient safety and optimizing outcomes in an evolving clinical landscape where “natural” does not equate to predictable or safe.
Here’s some of what you’ll hear in this episode:
🌿 Kratom acts as both a stimulant and opioid-like substance
⚠️ “Natural” does not mean safe or predictable
🧪 Potency and composition vary widely between products
😴 Patients may present with opioid tolerance or sedation
😵 Withdrawal can mimic pain, agitation, or delirium
“You may be walking into a pharmacologic minefield without realizing it.”
- Lynn & Garry
